Dette forventes at kunne forsinke eller forebygge udvikling af symptomer på Gauchers sygdom type 1 og reducere symptomerne på Niemann Picks sygdom type C.
This is expected to slow down or prevent the development of the symptoms of type 1 Gaucher disease and to reduce the symptoms of Niemann-Pick type C disease.